Sevelamer Carbonate 800 mg film coated tablets Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sevelamer carbonate 800 mg film coated tablets

generics (uk) limited - sevelamer carbonate - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer - treatment of hyperkalaemia and hyperphosphataemia - sevelamer carbonate is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. sevelamer carbonate is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus  1.78 mmol/l. sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) Európska únia - angličtina - EMA (European Medicines Agency)

sevelamer carbonate winthrop (previously sevelamer carbonate zentiva)

sanofi b.v. - sevelamer carbonate - hyperphosphatemia; renal dialysis - all other therapeutic products - sevelamer carbonate winthrop is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.sevelamer carbonate winthrop is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus > 1.78 mmol/l.sevelamer carbonate winthrop should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

ARX-SEVELAMER sevelamer carbonate 800 mg film-coated tablet bottle Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arx-sevelamer sevelamer carbonate 800 mg film-coated tablet bottle

dr reddys laboratories australia pty ltd - sevelamer carbonate, quantity: 800 mg - tablet, film coated - excipient ingredients: hyprolose; crospovidone; silicon dioxide; mannitol; zinc stearate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified talc; xanthan gum; polyvinyl alcohol; lecithin - arx-sevelamer is indicated for the management of hyperphosphataemia in adult patients with stage 4 and 5 chronic kidney disease.

SEVELAMER TARO 800 MG Izrael - angličtina - Ministry of Health

sevelamer taro 800 mg

taro international ltd, israel - sevelamer carbonate anhydrous - film coated tablets - sevelamer carbonate anhydrous 800 mg - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

SEVELAMER TARO 800 MG Izrael - angličtina - Ministry of Health

sevelamer taro 800 mg

taro international ltd, israel - sevelamer carbonate anhydrous - film coated tablets - sevelamer carbonate anhydrous 800 mg - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

SEVELAMER TARO 2.4 G Izrael - angličtina - Ministry of Health

sevelamer taro 2.4 g

taro international ltd, israel - sevelamer carbonate anhydrous - powder for suspension - sevelamer carbonate anhydrous 2.4 g - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l. should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

RENVELA sevelamer carbonate tablet film coated Spojené štáty - angličtina - NLM (National Library of Medicine)

renvela sevelamer carbonate tablet film coated

kaiser foundation hospitals - sevelamer carbonate (unii: 9ycx42i8iu) (sevelamer - unii:941n5duu5c) - sevelamer carbonate 800 mg

RENVELA sevelamer carbonate tablet film coated Spojené štáty - angličtina - NLM (National Library of Medicine)

renvela sevelamer carbonate tablet film coated

avera mckennan hospital - sevelamer carbonate (unii: 9ycx42i8iu) (sevelamer - unii:941n5duu5c) - sevelamer carbonate 800 mg

RENVELA sevelamer carbonate tablet film coated Spojené štáty - angličtina - NLM (National Library of Medicine)

renvela sevelamer carbonate tablet film coated

cardinal health - sevelamer carbonate (unii: 9ycx42i8iu) (sevelamer - unii:941n5duu5c) - sevelamer carbonate 800 mg

Sevelamer carbonate Genthon 800 mg, film-coated tablets Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sevelamer carbonate genthon 800 mg, film-coated tablets

genthon b.v. - sevelamer carbonate anhydrous - film-coated tablet - 800 milligram(s) - drugs for treatment of hyperkalemia and hyperphosphatemia; sevelamer